Xcout Intel
Atley Solutions
Atley Solutions is a global leader in commercial products and services for astatine-related (At-211) radiopharmaceutical development and scalable manufacturing, originating from research at the University of Gothenburg.
Subscribe to see Atley Solutions’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atley Solutions at a glance
Atley Solutions is a biotechnology company headquartered in Sweden. Its most recent funding round raised $5M in June 2025. Xcout tracks 7 named people at Atley Solutions, including Milton Lönnroth (CEO).
Atley Solutions leadership
- Milton LönnrothCEO
- Julia FranssonChief Operating Officer
- Fredrik SjövallChief Financial Officer
- Björn ErikssonChief Technology Officer
- Milton LönnrothCo-Founder & Chief Executive Officer
- Emma AneheimCo-Founder, Board Member & Chief Science Officer
1 more named person on record for Atley Solutions, with roles, board committees and tenure — see the full roster →
Atley Solutions funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $5M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Atley Solutions competitors
A few of Atley Solutions's closest competitors — see the full list of competitors and alternatives →
AdvanCell Isotopes Pty Ltd is an Australian medical-isotope company developing technologies to produce isotopes used in targeted radiopharmaceutical cancer treatments. It serves radiopharmaceutical developers, pharmaceutical companies, and nuclear-medicine providers seeking reliable supplies of therapeutic isotopes.
Genovis is a Swedish biotechnology company that develops and commercializes enzymes and enzyme-based technologies used in the development, characterization, and quality control of biopharmaceuticals. Its customers include pharmaceutical and biotechnology companies, as well as research and analytical laboratories.
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
Thor Medical produces and supplies alpha-particle emitters used in targeted cancer therapy and radionuclide treatments. The company utilizes a proprietary, environmentally friendly technology to extract radioactive decay products from thorium for medical applications.
Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.
ITM Isotope Technologies Munich SE develops and supplies targeted radiopharmaceuticals, including diagnostics and therapeutics, for cancer care. The company focuses on precision oncology treatments such as radioligand therapies for hard-to-treat tumors and produces medical radioisotopes like Lutetium-177 and Actinium-225 to serve patients globally.
Get Atley Solutions's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Atley Solutions in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access